What does PHARMATOPIA do?

PHARMATOPIA is a holding company in Beringen. Public Limited, started on 7 November 2023, 1 establishment.

What is the address of PHARMATOPIA?

The registered office of PHARMATOPIA is located at Heerbaan 232, 3582 Beringen.

Is PHARMATOPIA still active?

Yes. According to the CBE (30 September 2026) PHARMATOPIA is active, legal situation “Normale toestand”, started on 7 November 2023.

Is PHARMATOPIA registered on Peppol?

Yes, PHARMATOPIA is registered on the Peppol network with ID 0208:1002022767.

What is the enterprise number of PHARMATOPIA?

The enterprise number of PHARMATOPIA is BE1002022767.

When was PHARMATOPIA founded?

PHARMATOPIA was founded on 7 November 2023.

Who are the directors of PHARMATOPIA?

According to the 2025 annual accounts, the directors of PHARMATOPIA are: Rohecon BV, Syntaxxis NV, Greet Heynen, Borre BV, Barbara Verbeeck.

Is PHARMATOPIA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 November 2023; 1 annual account filed (fiscal year 2025); 5 directors known from the annual account.

How much profit did PHARMATOPIA make in 2025?

PHARMATOPIA posted a profit after taxes of € 139,178 in financial year 2025.

What is the revenue of PHARMATOPIA?

As a small company, PHARMATOPIA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 606,286.

How much does an employee at PHARMATOPIA earn?

The average wage cost per full-time employee at PHARMATOPIA was € 92,100 in 2025: staff costs of € 285,569 for 3.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMATOPIA have?

According to the 2025 annual accounts, PHARMATOPIA has 3.1 full-time equivalents (FTE).

PHARMATOPIA (Public Limited) - Beringen - BE1002022767

Dossier PHARMATOPIA, printed on 30 September 2026 from databakkes.be/en/1002022767/pharmatopia. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMATOPIA from Beringen, company number BE1002022767, closed financial year 2025 with a result of € 139,178 after tax. For that financial year PHARMATOPIA recorded a gross margin of € 606,286 and equity of € 182,178. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on December 5, 2025.

What it is worth Healthy

€ 182,178

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 139,178

Profit after tax over the fiscal year.

Cash in the bank

€ 58,750

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 20,000 paid out

14 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

3.1

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 285,569

€ 92,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 33 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 2.5 million

€ 75,332 is repaid this year. At this pace the long-term loan is gone in ≈ 33 years.

Owed to suppliers

€ 26,304

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 47,376

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

What happened to PHARMATOPIA?

What happened at PHARMATOPIA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 5, 2025 New annual accounts for financial year 2025: profit of € 139,178. Source: NBB ↗
Nov 7, 2023 New establishment in Beringen. KBO
2023 Rohecon BV became a director. NBB
2023 Syntaxxis NV became a director. NBB
2023 Greet Heynen became a director. NBB
2023 Borre BV became a director. NBB
2023 Barbara Verbeeck became a director. NBB
Nov 7, 2023 Start of the company according to the CBE. KBO

In short

Paid € 41,858 in corporate taxes since 2025.

On average € 195,600 of value added per employee in 2025.

Paid out € 20,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMATOPIA? We notify you, reason included.

Follow PHARMATOPIA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Rohecon BV

Syntaxxis NV

Greet Heynen

Borre BV

PHARMATOPIA

Pharmaconsult 100%

Apotheek Van Bulck 100%

Behind PHARMATOPIA are Rohecon BV, Syntaxxis NV, Greet Heynen, Borre BV and Barbara Verbeeck. It owns 100% of Pharmaconsult and 100% of Apotheek Van Bulck itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Rohecon BV

Director · represented by Roels STEFAAN

since 2023

Syntaxxis NV

Director · represented by Patyn TOON

Also active at: Pharmaconsult

since 2023

Greet Heynen

Managing director

Also active at: ROHECON

since 2023

Borre BV

Director · represented by Van DESSEL CHRISTOF

Also active at: ABC-GROEP

since 2023

Barbara Verbeeck

Managing director

Also active at: SYNTAXXIS

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Heerbaan 232

3582 Beringen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Pharmaconsult same network

€ 75,930 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

1002.022.767

VAT number

BE 1002.022.767

Registered office

Heerbaan 232, 3582 Beringen

Names & denominations

PHARMATOPIA

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

7 November 2023

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Activiteiten van hoofdkantoren

Activiteiten van holdings

Holdings

Detailhandel in farmaceutische producten

Overige vormen van onderwijs

Overige dienstverlenende activiteiten op het gebied van informatie

Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMATOPIA

Financials

What happened to PHARMATOPIA?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions